Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.
Also called NCT01102413
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 351 participants
- Sponsor
- Registry
-
NCT01102413
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT01102413. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2015-12-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
- Condition
- Iron Deficiency Anemia
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Monofer
- Intervention (Drug)
- Iron Sulphate
- Lead sponsor
- Pharmacosmos A/S
Record details
- Record id
cardio:ct-nct01102413- Content hash
774b277328cc60a176c184946c676fa3de0e8fd7fff92814c1fbad0358f201aa